The Europe medical marijuana market is projected to make US$ 13,801.0 million by 2028 from US$ 492.1 million which was made in 2021. 

The market is estimated to grow with a compound annual growth rate of 61.1% from 2022 to 2028. While it is unusual for government officials to encourage health professionals to be taught about marijuana herbal medicines, there are a considerable number of countries adopting medical marijuana laws. The market growth is mostly credited to factors such as growing research activities on the medicinal use of marijuana and growing government funding and a more potent spotlight on marijuana use.

It was Reportlinker.com that released the report "Europe Medical Cannabis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type, Medical Application, Compound, and Country" -

In particular, in Macedonia, where the health system is at a phase of development and modernization, there are marijuana offers unique opportunities in. Local health professionals are now able to order marijuana in the country. The uprising in medical marijuana in this particular region provokes the European Commission and Member States to address regulatory, economic and cultural hurdles that trouble systematic studies about marijuana and encourage those in power to fund research. Equally, funds to accelerate R&D activities on marijuana use for COVID-19 were granted by the government in September 2020. EXMceuticals Inc. was the ones that made the announcement.  

Despite the disadvantages the Marijuana Market has in place, the aforementioned progression is a clear indicator that the medical marijuana market is anticipated to grow at a fast pace during the estimated period.